We’ve gotten used to crowdsourcing to fund everything from documentaries to startup clothing lines, but what about advances in diabetes care? Two new fundraising campaigns are crowdsourcing to raise money to foster innovative ways to treat Type 1 diabetes.

In March, Timesulin launched a campaign on Indigogo to raise $30,000 to bring its timer-enabled insulin pen caps to the U.S. The funds raised will go towards the costs of registering with the FDA, as well as consulting fees to navigate the FDA approval process. While diabetes tech companies have raised funds through crowdsourcing campaigns before, this might be the first time that a company is targeting a fundraising campaign to deal specifically with regulatory costs.